368 related articles for article (PubMed ID: 17617052)
1. Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia.
Basri N; Gendo MZ; Haider R; Abdullah KA; Hassan A; Shaheen FA
Exp Clin Transplant; 2007 Jun; 5(1):607-9. PubMed ID: 17617052
[TBL] [Abstract][Full Text] [Related]
2. Erythrocytosis after renal transplantation: review of 101 cases.
Einollahi B; Lessan-Pezeshki M; Nafar M; Pour-Reza-Gholi F; Firouzan A; Farhangi F; Pourfarziani V
Transplant Proc; 2005 Sep; 37(7):3101-2. PubMed ID: 16213319
[TBL] [Abstract][Full Text] [Related]
3. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.
Montanaro D; Groupuzzo M; Boscutti G; Risaliti A; Bresadola F; Mioni G
Clin Nephrol; 2000 Apr; 53(4):suppl 47-51. PubMed ID: 10809436
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitor-induced anemia and treatment for erythrocytosis in renal transplant recipients.
Satoh S; Kaneko T; Seino K; Abe T; Omori S; Sugimura J; Fujioka T; Kubo T
Nihon Jinzo Gakkai Shi; 1995 Jun; 37(6):343-7. PubMed ID: 7666600
[TBL] [Abstract][Full Text] [Related]
5. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.
Torregrosa JV; Campistol JM; Montesinos M; Rogada AG; Oppenheimer F; Andreu J
Transplantation; 1994 Aug; 58(3):311-4. PubMed ID: 8053053
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience.
Dehghani SM; Derakhshan A; Taghavi SA; Gholami S; Jalaeian H; Malek-Hosseini SA
Exp Clin Transplant; 2008 Mar; 6(1):25-9. PubMed ID: 18405241
[TBL] [Abstract][Full Text] [Related]
8. Effects of losartan on the treatment of posttransplant erythrocytosis.
Navarro JF; García J; Macía M; Mora C; Chahin J; Gallego E; Méndez ML; del Castillo N
Clin Nephrol; 1998 Jun; 49(6):370-2. PubMed ID: 9696433
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period.
Formica RN; Friedman AL; Lorber MI; Bia MJ
Transplant Proc; 2004 Nov; 36(9):2675-8. PubMed ID: 15621121
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of anemia in renal transplant patients: results from MOST, an observational trial.
Fernández Fresnedo G; Palomar R; Rodrigo E; Ruiz JC; de Francisco AL; Cotorruelo JG; Arias M
Transplant Proc; 2005 Nov; 37(9):3821-2. PubMed ID: 16386550
[TBL] [Abstract][Full Text] [Related]
11. Erythrocytosis after renal transplantation. A prospective analysis.
Sumrani NB; Daskalakis P; Miles AM; Sarkar S; Markell MS; Hong JH; Friedman EA; Sommer BG
ASAIO J; 1993; 39(1):51-5. PubMed ID: 8439681
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficiency of phlebotomy in posttransplant hypertension associated with erythrocytosis.
Barenbrock M; Spieker C; Rahn KH; Zidek W
Clin Nephrol; 1993 Oct; 40(4):241-3. PubMed ID: 8261683
[TBL] [Abstract][Full Text] [Related]
13. Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients.
Akcay A; Kanbay M; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
Transplant Proc; 2005 Sep; 37(7):3103-5. PubMed ID: 16213320
[TBL] [Abstract][Full Text] [Related]
14. Valsartan-induced hematocrit changes in renal transplant patients.
Flores CA; Ardiles LG; Aros CA; Muñoz CC; Schneider HO; Ramírez JA; Jerez V; Valderrama MG; Mezzano SA
Transplant Proc; 2005 Apr; 37(3):1586-8. PubMed ID: 15866681
[TBL] [Abstract][Full Text] [Related]
15. Correction of posttransplant erythrocytosis with enalapril.
Rell K; Koziak K; Jarzyo I; Lao M; Gaciong Z
Transplantation; 1994 Apr; 57(7):1059-63. PubMed ID: 8165703
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and prognosis for proteinuria in renal transplant recipients.
Sancho A; Gavela E; Avila A; Morales A; Fernández-Nájera JE; Crespo JF; Pallardo LM
Transplant Proc; 2007 Sep; 39(7):2145-7. PubMed ID: 17889119
[TBL] [Abstract][Full Text] [Related]
17. Ramipril in post-renal transplant erythrocytosis.
Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
[TBL] [Abstract][Full Text] [Related]
18. Factors predisposing to post-renal transplant erythrocytosis: a retrospective study.
Charfeddine K; Zaghdane S; Yaich S; Hakim A; Hachicha J
Saudi J Kidney Dis Transpl; 2008 May; 19(3):371-7. PubMed ID: 18445895
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant erythrocytosis: a review of 47 renal transplant recipients.
Abdelrahman M; Rafi A; Ghacha R; Qayyum T; Karkar A
Saudi J Kidney Dis Transpl; 2004; 15(4):433-9. PubMed ID: 17642778
[TBL] [Abstract][Full Text] [Related]
20. Influence of angiotensin I-converting enzyme polymorphism on development of post-transplant erythrocytosis in renal graft recipients.
Kedzierska K; Kabat-Koperska J; Safranow K; Domański M; Gołembiewska E; Bober J; Bohatyrewicz R; Ciechanowski K
Clin Transplant; 2008; 22(2):156-61. PubMed ID: 18339134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
